Stephen Levin
Prior to co-founding Innovation In Medtech, Stephen Levin served as Editor-in-Chief of Medical Devices for Elsevier Business Intelligence, where he directed the company’s editorial coverage of the medical device industry, following Elsevier’s acquisition of Windhover Information in 2008. This included managing the device content for the following publications: IN VIVO, START-UP, MEDTECH INSIGHT, The Gray Sheet, and The Silver Sheet, along with the IN3 medical device partnering conference series.
Stephen Levin joined Windhover Information in 1997, where as Executive Editor, he specialised in covering the device industry, distribution, and legal issues. He also served as the company’s General Counsel. He also formerly was an Editor of Health Industry Today, a leading publication in the healthcare industry.
Prior to joining Windhover, Stephen Levin was Senior Counsel to the U.S. Senate Permanent Subcommittee on Investigations, where he directed Senate investigations into a wide variety of areas including healthcare fraud and abuse, international organised crime, and corruption in federal contracting programmes, while also participating in other Senate investigations including the Whitewater inquiry. Before joining the Subcommittee, he was with the Federal Election Commission (enforcement and regulatory counsel) and the Department of Justice (international criminal law).
Latest contributions
Regulatory and reimbursement pathways for MedTech innovators
19 May 2026 – From EuroPCR 2026
This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the...
Artificial intelligence and advanced imaging in coronary interventions
19 May 2026 – From EuroPCR 2026
This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...
The thin line between success and failure in MedTech start ups - Lessons learnt
18 May 2026 – From EuroPCR 2026
This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.
PCR Innovators Day Steering commitee
09 Jan 2017
Join the major actors in the field of innovation in interventional cardiology! Find out about the Steering Committee